Examination Report |
1 | TM-1 | 13 Aug 2014 |
2 | Authorization Document (POA) | 13 Aug 2014 |
3 | Reply to Exam Report (MIS-R) | 16 Feb 2016 |
4 | Journal Copy | 15 Nov 2018 |
5 | TM-O(NOTICE OF OPPOSITION) | 16 Jan 2019 |
6 | Evidence Affidavit Under Rule 46 (TOP) | 29 Nov 2019 |
7 | Annexure -1 under rule 46 | 29 Nov 2019 |
8 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 09 Apr 2024 |
9 | Note Sheet | 10 Apr 2024 |
1 | Dispatching of Examination Report for : 2790956 | 2908893 | 1476400 | 27 Jan 2016 |
2 | Dispatching of Examination Report for : 2790956 | 2909385 | 1476400 | 27 Jan 2016 |
3 | Dispatching of Examination Report for : 2790956 | 2909401 | 1476400 | 27 Jan 2016 |
4 | Hearing Notice (Show Cause) | 6662263 | 3031523 | 13 Jul 2018 |
5 | Tribunal Accepted Notice for : 2790956 | 6977397 | 3201129 | 12 Sep 2018 |
6 | Opposition Notice | 8239605 | 4056449 | 09 May 2019 |
7 | Opposition Counter Statement | 8737303 | 4316574 | 08 Aug 2019 |
8 | Hearing Notice | 17658115 | 6616509 | 08 Mar 2024 |
The application for Dipronil was made on 13 August 2014.
The trademark applicant for Dipronil is TRIVET PHARMACEUTICALS.
Dipronil is applied in class(es) 5.
Application for Dipronil is on Opposed stage.
Application Id allotted to Dipronil is 2790956.
Trademark agent or attorney for the application is Lalji Advocates.
Dipronil filed with the Intellectual property office as a WORD.